SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-22-015598
Filing Date
2022-11-21
Accepted
2022-11-21 09:30:23
Documents
1
Period of Report
2022-11-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 2751
  Complete submission text file 0001654954-22-015598.txt   4435
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXZA PHARMACEUTICALS INC 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Oki Mark K (Reporting) CIK: 0001491847 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 221403742